| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2022-06-03 | Versant Ventures V, LLC | - | Sell | 264,611 | $12.25 | $3,241,934.59 | -10.0% | → |
| 2022-06-03 | Versant Vantage I, L.P. | - | Sell | 466,605 | $12.25 | $5,716,704.48 | -23.0% | → |
| 2022-06-03 | Jerel Davis | - | Sell | 61,205 | $12.25 | $749,865.30 | -23.1% | → |
| 2022-06-03 | BVF PARTNERS L P/IL | - | Buy | 1,830,089 | $11.89 | $21,768,576.69 | +13.5% | → |
| 2022-05-18 | BVF PARTNERS L P/IL | - | Buy | 420,000 | $8.50 | $3,570,000.00 | +7.3% | → |
| 2022-03-15 | Zinda Michael | EVP, Chief Science Officer | Sell | 533 | $11.30 | $6,022.90 | -1.1% | → |
| 2022-01-19 | BVF PARTNERS L P/IL | - | Buy | 997,961 | $14.10 | $14,071,250.10 | +21.0% | → |
| 2021-11-16 | Civik Thomas | - | Buy | 7,500 | $28.08 | $210,600.00 | New | → |
| 2021-11-15 | Zinda Michael | EVP, Chief Science Officer | Sell | 20,000 | $27.33 | $546,613.00 | -80.1% | → |
| 2021-09-07 | Bonita David P | - | Sell | 8,084 | $33.99 | $274,793.91 | -0.1% | → |
| 2021-09-07 | ORBIMED ADVISORS LLC | - | Sell | 8,084 | $33.99 | $274,793.91 | -0.1% | → |
| 2021-09-02 | ORBIMED ADVISORS LLC | - | Sell | 37,864 | $34.08 | $1,290,550.08 | -0.4% | → |
| 2021-09-02 | Bonita David P | - | Sell | 37,864 | $34.08 | $1,290,550.08 | -0.4% | → |
| 2021-08-30 | Bonita David P | - | Sell | 13,581 | $33.93 | $460,805.20 | -0.2% | → |
| 2021-08-30 | ORBIMED ADVISORS LLC | - | Sell | 6,906 | $33.92 | $234,255.70 | -0.2% | → |